Singh, A. A., Banez, L. L., Gerber, L., Freedland, S. J., Robertson, C. N., Ferrandino, M., … Moul, J. W. (2012). Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30). AMER SOC CLINICAL ONCOLOGY. https://doi.org/10.1200/jco.2012.30.5_suppl.34

Singh, Abhay A., Lionel Lloyds Banez, Leah Gerber, Stephen J. Freedland, Cary N. Robertson, Michael Ferrandino, Thomas Polascik, Philip John Walther, and Judd W. Moul. “Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012. https://doi.org/10.1200/jco.2012.30.5_suppl.34.

Singh AA, Banez LL, Gerber L, Freedland SJ, Robertson CN, Ferrandino M, et al. Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.

Singh, Abhay A., et al. “Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database.” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 5, AMER SOC CLINICAL ONCOLOGY, 2012. Wos, doi:10.1200/jco.2012.30.5_suppl.34.

Singh AA, Banez LL, Gerber L, Freedland SJ, Robertson CN, Ferrandino M, Polascik T, Walther PJ, Moul JW. Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.